资讯
StockStory.org on MSN14 小时
Medpace (NASDAQ:MEDP) Beats Expectations in Strong Q1 But Stock DropsClinical research company Medpace Holdings (NASDAQ:MEDP) announced in Q1 CY2025, with sales up 9.3% year on year to $558.6 ...
BTIG analyst Mark Massaro has initiated coverage on Tempus AI (TEM), with a Buy rating and a price target of $60, implying 48 ...
Ace investor and one of the Warren Buffet’s of India, Sunil Singhania, the man behind Abakkus Asset Management, has just made ...
StockStory.org on MSN21 小时
1 Cash-Producing Stock to Target This Week and 2 to IgnoreGenerating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of ...
Both are free and provide excellent research, screening tools, and a range of account types. Plus, unlike many free stock apps, E*TRADE from Morgan Stanley allows mutual fund and bond trading ...
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, ...
I believe Microsoft’s exclusive game titles and subscription services will drive significant revenue growth. Read why MSFT ...
1 天
24/7 Wall St. on MSNShould You Buy 2025’s 3 New Dividend Aristocrats?Dividend stock investing has proved to be a superior investing strategy. Data from Hartford Funds and Ned Davis Research show ...
Riley Exploration Permian leverages its prime location, focusing on low-cost conventional wells. Read why REPX stock is a ...
This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果